/term/cyclically-adjusted-fcf/PHMMF PHMMF (Pharma Mar) Cyclically Adjusted FCF per Share
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (OTCPK:PHMMF) » Definitions » Cyclically Adjusted FCF per Share

Pharma Mar (Pharma Mar) Cyclically Adjusted FCF per Share : $1.54 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Pharma Mar Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Pharma Mar's adjusted free cash flow per share for the three months ended in Mar. 2024 was $0.125. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $1.54 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Pharma Mar's average Cyclically Adjusted FCF Growth Rate was -14.20% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 6.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Pharma Mar was 6.40% per year. The lowest was -5.70% per year. And the median was 0.35% per year.

As of today (2024-06-20), Pharma Mar's current stock price is $31.15. Pharma Mar's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $1.54. Pharma Mar's Cyclically Adjusted Price-to-FCF of today is 20.23.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Pharma Mar was 143.81. The lowest was 17.18. And the median was 37.15.


Pharma Mar Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Pharma Mar's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Cyclically Adjusted FCF per Share Chart

Pharma Mar Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.43 1.56 1.66 1.88 1.72

Pharma Mar Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.76 2.07 1.73 1.72 1.54

Competitive Comparison of Pharma Mar's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Pharma Mar's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Mar's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Pharma Mar's Cyclically Adjusted Price-to-FCF falls into.



Pharma Mar Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pharma Mar's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.125/122.7621*122.7621
=0.125

Current CPI (Mar. 2024) = 122.7621.

Pharma Mar Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.372 101.081 -0.452
201409 0.320 100.441 0.391
201412 0.372 100.251 0.456
201503 -0.130 99.474 -0.160
201506 -0.858 101.138 -1.041
201509 0.150 99.559 0.185
201512 0.917 100.268 1.123
201603 -0.796 98.638 -0.991
201606 -0.355 100.333 -0.434
201609 -0.011 99.737 -0.014
201612 0.268 101.842 0.323
201703 0.489 100.896 0.595
201706 -0.618 101.848 -0.745
201709 -0.242 101.524 -0.293
201712 -0.043 102.975 -0.051
201803 -0.637 102.122 -0.766
201806 -0.807 104.165 -0.951
201809 0.020 103.818 0.024
201812 0.199 104.193 0.234
201903 -0.905 103.488 -1.074
201906 -0.050 104.612 -0.059
201909 -0.710 103.905 -0.839
201912 -0.041 105.015 -0.048
202003 10.522 103.469 12.484
202006 5.600 104.254 6.594
202009 -0.027 103.521 -0.032
202012 0.602 104.456 0.708
202103 0.837 104.857 0.980
202106 -0.148 107.102 -0.170
202109 0.588 107.669 0.670
202112 -0.105 111.298 -0.116
202203 2.159 115.153 2.302
202206 -0.078 118.044 -0.081
202209 0.208 117.221 0.218
202212 -0.486 117.650 -0.507
202303 0.441 118.948 0.455
202306 -1.018 120.278 -1.039
202309 -0.690 121.343 -0.698
202312 -0.519 121.300 -0.525
202403 0.125 122.762 0.125

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Pharma Mar  (OTCPK:PHMMF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Pharma Mar's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=31.15/1.54
=20.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Pharma Mar was 143.81. The lowest was 17.18. And the median was 37.15.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Pharma Mar Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Mar (Pharma Mar) Business Description

Industry
Traded in Other Exchanges
Address
Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.

Pharma Mar (Pharma Mar) Headlines